Quantamental Technologies’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,735
Closed -$236K 353
2023
Q2
$236K Buy
+1,735
New +$212K 0.1% 348
2022
Q3
Sell
-2,212
Closed -$212K 524
2022
Q2
$212K Buy
+2,212
New +$265K 0.1% 342
2020
Q1
Sell
-2,365
Closed -$264K 178
2019
Q4
$264K Buy
2,365
+1,403
+146% +$150K 0.14% 290
2019
Q3
$92K Buy
+962
New +$90.3K 0.03% 769
2019
Q2
Sell
-3,822
Closed -$318K 1507
2019
Q1
$318K Buy
3,822
+1,317
+53% +$95.7K 0.15% 221
2018
Q4
$161K Buy
+2,505
New +$171K 0.1% 388

Other funds holding CNMD

Quantamental Technologies's CNMD Position: Q3 2023 in Review

Quantamental Technologies sold out of CONMED (CNMD) in Q3 2023, closing a stake of 1,735 shares — an estimated $236K sold.

Quantamental Technologies first reported a position in CNMD in Q4 2018 and held it in 6 quarters. The position peaked at $318K in Q1 2019. 275 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

  • Quantamental Technologies reported no remaining CONMED position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 1,735 CONMED shares in Q3 2023, an estimated $236K.
  • Quantamental Technologies first reported a position in CONMED in Q4 2018 and held it in 6 quarters.
  • Quantamental Technologies's CONMED position peaked at $318K in Q1 2019.
  • 275 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.